It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.

Endogenex today reported positive findings from studies of its endoscopic procedure aimed at transforming diabetes care.

Ambu has received expanded FDA 510(k) clearance for its aScope 5 Cysto HD, making it the first single-use flexible ...

Johnson & Johnson MedTech announced today that it launched new variable angle optimized locking technology (VOLT) plating ...

Levita Magnetics announced today that it received expanded FDA 510(k) clearance for its MARS (magnetic-assisted robotic ...

Regeneron Pharmaceuticals had previously agreed to acquire the company for $256 million. TTAM’s higher bid and added consumer ...

Shifamed‘s Adona Medical announced today that it completed enrollment in the ATHENS-HF first-in-human study of its ...

Surgical robot technology developer Virtual Incision announced today that it appointed Jim Alecxih as its new CEO.

EBR Systems announced today that it completed a security purchase plan to bring in about $13 million (A$20 million) in ...

Smith+Nephew (NYSE: SNN) + Smith & Nephew plc $28.624 2.34% Open 29.47 Day High 29.648 52 Week High 31.13 52 Week Low 21.13 ...

Brain Navi Biotechnology announced today that it received FDA 510(k) clearance for its NaoTrac stereotaxic guiding surgical ...

Penumbra (NYSE:PEN) announced today that it completed enrollment in the STORM-PE trial of its Lightning Flash system.